{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:32:25Z","timestamp":1770838345547,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007176","name":"Scuola Superiore Sant'Anna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007176","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To assess the cost-effectiveness (CE) of transcatheter aortic valve implantation (TAVI) in Italy, considering patient groups with different surgical risk.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A Markov model with a 1-month cycle length, comprising eight different health states, defined by the New York Heart Association functional classes (NYHA I\u2013IV), with and without stroke plus death, was used to estimate the CE of TAVI for intermediate-, high-risk and inoperable patients considering surgical aortic valve replacement or medical treatment as comparators according to the patient group. The Italian National Health System perspective and 15-year time horizon were considered. In the base-case analysis, effectiveness data were retrieved from published efficacy data and total direct costs (euros) were estimated from national tariffs. A scenario analysis considering a micro-costing approach to estimate procedural costs was also considered. The incremental cost-effectiveness ratio (ICER) was expressed both in terms of costs per life years gained (LYG) and costs per quality adjusted life years (QALY). All outcomes and costs were discounted at 3% per annum. Univariate and probabilistic sensitivity analyses (PSA) were performed to assess robustness of results.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Over a 15-year time horizon, the higher acquisition costs for TAVI were partially offset in all risk groups because of its effectiveness and safety profile. ICERs were \u20ac8338\/QALY, \u20ac11,209\/QALY and \u20ac10,133\/QALY, respectively, for intermediate-, high-risk and inoperable patients. ICER values were slightly higher in the scenario analysis. PSA suggested consistency of results.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>TAVI would be considered cost-effective at frequently cited willingness-to-pay thresholds; further studies could clarify the CE of TAVI in real-life scenarios.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10198-021-01314-z","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T09:04:25Z","timestamp":1621587865000},"page":"1349-1363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The cost-effectiveness of transcatheter aortic valve implantation: exploring the Italian National Health System perspective and different patient risk groups"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9948-0301","authenticated-orcid":false,"given":"V.","family":"Lorenzoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Saia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Meucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. L.","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. G.","family":"Cerillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Berti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Candolfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Turchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,21]]},"reference":[{"key":"1314_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.05.015","author":"RLJ Osnabrugge","year":"2013","unstructured":"Osnabrugge, R.L.J., Mylotte, D., Head, S.J., Van Mieghem, N.M., Nkomo, V.T., Lereun, C.M., Bogers, A.J.J.C., Piazza, N., Kappetein, A.P.: Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J. Am. Coll. Cardiol. (2013). https:\/\/doi.org\/10.1016\/j.jacc.2013.05.015","journal-title":"J. Am. Coll. Cardiol."},{"key":"1314_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69208-8","author":"VT Nkomo","year":"2006","unstructured":"Nkomo, V.T., Gardin, J.M., Skelton, T.N., Gottdiener, J.S., Scott, C.G., Enriquez-Sarano, M.: Burden of valvular heart diseases: a population-based study. Lancet (2006). https:\/\/doi.org\/10.1016\/S0140-6736(06)69208-8","journal-title":"Lancet"},{"key":"1314_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx391","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner, H., Falk, V., Bax, J.J., De Bonis, M., Hamm, C., Holm, P.J., Iung, B., Lancellotti, P., Lansac, E., Mu, D.R., Rosenhek, R., Sj\u00f6gren, J., Mas, P.T., Vahanian, A., Walther, T., Wendler, O., Windecker, S., Zamorano, J.L., Agewall, S., Ahlsson, A., Barbato, E., Ctor Bueno, H., Collet, J.P., Gaemperli, O., Habib, G., Harringer, W., Haude, M.: 2017 ESC\/EACTS Guidelines for the management of valvular heart disease. The Task Force for the Management of Valvular Heart Disease. Eur. Heart J. (2017). https:\/\/doi.org\/10.1093\/eurheartj\/ehx391","journal-title":"Eur. Heart J."},{"key":"1314_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2009.05.053","author":"DM Shahian","year":"2009","unstructured":"Shahian, D.M., O\u2019Brien, S.M., Filardo, G., Ferraris, V.A., Haan, C.K., Rich, J.B., Normand, S.L.T., DeLong, E.R., Shewan, C.M., Dokholyan, R.S., Peterson, E.D., Edwards, F.H., Anderson, R.P.: The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1-coronary artery bypass grafting surgery. Ann. Thorac. Surg. (2009). https:\/\/doi.org\/10.1016\/j.athoracsur.2009.05.053","journal-title":"Ann. Thorac. Surg."},{"key":"1314_CR5","doi-asserted-by":"crossref","unstructured":"Roques, F., Michel, P., Goldstone, A.R., Nashef, S.A.M.: The logistic EuroSCORE [3], (2003).","DOI":"10.1016\/S0195-668X(02)00799-6"},{"key":"1314_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy107","author":"AP Durko","year":"2018","unstructured":"Durko, A.P., Osnabrugge, R.L., Van Mieghem, N.M., Milojevic, M., Mylotte, D., Nkomo, V.T., Pieter Kappetein, A.: Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projections. Eur. Heart J. (2018). https:\/\/doi.org\/10.1093\/eurheartj\/ehy107","journal-title":"Eur. Heart J."},{"key":"1314_CR7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1514616","author":"MB Leon","year":"2016","unstructured":"Leon, M.B., Smith, C.R., Mack, M.J., Makkar, R.R., Svensson, L.G., Kodali, S.K., Thourani, V.H., Tuzcu, E.M., Miller, D.C., Herrmann, H.C., Doshi, D., Cohen, D.J., Pichard, A.D., Kapadia, S., Dewey, T., Babaliaros, V., Szeto, W.Y., Williams, M.R., Kereiakes, D., Zajarias, A., Greason, K.L., Whisenant, B.K., Hodson, R.W., Moses, J.W., Trento, A., Brown, D.L., Fearon, W.F., Pibarot, P., Hahn, R.T., Jaber, W.A., Anderson, W.N., Alu, M.C., Webb, J.G.: PARTNER 2 investigators: transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N. Engl. J. Med. (2016). https:\/\/doi.org\/10.1056\/NEJMoa1514616","journal-title":"N. Engl. J. Med."},{"key":"1314_CR8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1814052","author":"MJ Mack","year":"2019","unstructured":"Mack, M.J., Leon, M.B., Thourani, V.H., Makkar, R., Kodali, S.K., Russo, M., Kapadia, S.R., Malaisrie, S.C., Cohen, D.J., Pibarot, P., Leipsic, J., Hahn, R.T., Blanke, P., Williams, M.R., McCabe, J.M., Brown, D.L., Babaliaros, V., Goldman, S., Szeto, W.Y., Genereux, P., Pershad, A., Pocock, S.J., Alu, M.C., Webb, J.G., Smith, C.R.: Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N. Engl. J. Med. (2019). https:\/\/doi.org\/10.1056\/NEJMoa1814052","journal-title":"N. Engl. J. Med."},{"key":"1314_CR9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816885","author":"JJ Popma","year":"2019","unstructured":"Popma, J.J., Deeb, G.M., Yakubov, S.J., Mumtaz, M., Gada, H., O\u2019Hair, D., Bajwa, T., Heiser, J.C., Merhi, W., Kleiman, N.S., Askew, J., Sorajja, P., Rovin, J., Chetcuti, S.J., Adams, D.H., Teirstein, P.S., Zorn, G.L., Forrest, J.K., Tch\u00e9tch\u00e9, D., Resar, J., Walton, A., Piazza, N., Ramlawi, B., Robinson, N., Petrossian, G., Gleason, T.G., Oh, J.K., Boulware, M.J., Qiao, H., Mugglin, A.S., Reardon, M.J.: Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N. Engl. J. Med. (2019). https:\/\/doi.org\/10.1056\/NEJMoa1816885","journal-title":"N. Engl. J. Med."},{"key":"1314_CR10","unstructured":"GISE\u2014Societ\u00e0 Italiana di Cardiologia Interventistica, https:\/\/gise.it\/statisticheNazionali"},{"key":"1314_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2017.10.008","author":"S Kodera","year":"2018","unstructured":"Kodera, S., Kiyosue, A., Ando, J., Komuro, I.: Cost effectiveness of transcatheter aortic valve implantation in patients with aortic stenosis in Japan. J. Cardiol. (2018). https:\/\/doi.org\/10.1016\/j.jjcc.2017.10.008","journal-title":"J. Cardiol."},{"key":"1314_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2014-000155","author":"S Brecker","year":"2014","unstructured":"Brecker, S., Mealing, S., Padhiar, A., Eaton, J., Sculpher, M., Busca, R., Bosmans, J., Gerckens, U.J., Wenaweser, P., Tamburino, C., Bleiziffer, S., Piazza, N., Moat, N., Linke, A.: Cost\u2013utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost\u2013utility analysis based on patient-level data from the ADVANCE study. Open Heart. (2014). https:\/\/doi.org\/10.1136\/openhrt-2014-000155","journal-title":"Open Heart"},{"key":"1314_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.09.018","author":"MR Reynolds","year":"2012","unstructured":"Reynolds, M.R., Magnuson, E.A., Lei, Y., Wang, K., Vilain, K., Li, H., Walczak, J., Pinto, D.S., Thourani, V.H., Svensson, L.G., MacK, M.J., Miller, D.C., Satler, L.E., Bavaria, J., Smith, C.R., Leon, M.B., Cohen, D.J.: Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J. Am. Coll. Cardiol. (2012). https:\/\/doi.org\/10.1016\/j.jacc.2012.09.018","journal-title":"J. Am. Coll. Cardiol."},{"key":"1314_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.09.018","author":"MR Reynolds","year":"2012","unstructured":"Reynolds, M.R., Magnuson, E.A., Lei, Y., Wang, K., Vilain, K., Li, H., Walczak, J., Pinto, D.S., Thourani, V.H., Svensson, L.G., Mack, M.J., Miller, D.C., Satler, L.E., Bavaria, J., Smith, C.R., Leon, M.B., Cohen, D.J.: Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis. J. Am. Coll. Cardiol. (2012). https:\/\/doi.org\/10.1016\/j.jacc.2012.09.018","journal-title":"J. Am. Coll. Cardiol."},{"key":"1314_CR15","doi-asserted-by":"crossref","unstructured":"Osnabrugge, R.L.J., Kappetein, A.P., Reynolds, M.R., Cohen, D.J.: Cost-effectiveness of transcatheter valvular interventions: Economic challenges. (2013).","DOI":"10.4244\/EIJV9SSA10"},{"key":"1314_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2011-300444","author":"M Watt","year":"2012","unstructured":"Watt, M., Mealing, S., Eaton, J., Piazza, N., Moat, N., Brasseur, P., Palmer, S., Busca, R., Sculpher, M.: Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart (2012). https:\/\/doi.org\/10.1136\/heartjnl-2011-300444","journal-title":"Heart"},{"key":"1314_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2017.11.112","author":"DY Tam","year":"2018","unstructured":"Tam, D.Y., Hughes, A., Fremes, S.E., Youn, S., Hancock-Howard, R.L., Coyte, P.C., Wijeysundera, H.C.: A cost\u2013utility analysis of transcatheter versus surgical aortic valve replacement for the treatment of aortic stenosis in the population with intermediate surgical risk. J. Thorac. Cardiovasc. Surg. (2018). https:\/\/doi.org\/10.1016\/j.jtcvs.2017.11.112","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"1314_CR18","unstructured":"Health technology assessment of TAVI in patients with severe symptomatic aortic stenosis at low and intermediate risk of surgical complications Health Information and Quality Authority Health Technology Assessment of transcatheter aortic valve implantation (TAVI) in patients with severe symptomatic aortic stenosis at low and intermediate risk of surgical complications. (2019)."},{"key":"1314_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/17434440.2019.1555465","author":"A Solomonica","year":"2019","unstructured":"Solomonica, A., Choudhury, T., Bagur, R.: Newer-generation of Edwards transcatheter aortic valve systems: SAPIEN 3, Centera, and SAPIEN 3 Ultra. Expert Rev. Med. Devices. (2019). https:\/\/doi.org\/10.1080\/17434440.2019.1555465","journal-title":"Expert Rev. Med. Devices."},{"key":"1314_CR20","doi-asserted-by":"publisher","DOI":"10.4244\/EIJV8I7A121","author":"A Pieter Kappetein","year":"2012","unstructured":"Pieter Kappetein, A., Head, S.J., G\u00e9n\u00e9reux, P., Piazza, N., Van Mieghem, N.M., Blackstone, E.H., Brott, T.G., Cohen, D.J., Cutlip, D.E., Van Es, G.A., Hahn, R.T., Kirtane, A.J., Krucoff, M.W., Kodali, S., Mack, M.J., Mehran, R., Rod\u00e9s-Cabau, J., Vranckx, P., Webb, J.G., Windecker, S., Serruys, P.W., Leon, M.B.: Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document. EuroIntervention (2012). https:\/\/doi.org\/10.4244\/EIJV8I7A121","journal-title":"EuroIntervention"},{"key":"1314_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60308-7","author":"MJ Mack","year":"2015","unstructured":"Mack, M.J., Leon, M.B., Smith, C.R., Miller, D.C., Moses, J.W., Tuzcu, E.M., Webb, J.G., Douglas, P.S., Anderson, W.N., Blackstone, E.H., Kodali, S.K., Makkar, R.R., Fontana, G.P., Kapadia, S., Bavaria, J., Hahn, R.T., Thourani, V.H., Babaliaros, V., Pichard, A., Herrmann, H.C., Brown, D.L., Williams, M., Davidson, M.J., Svensson, L.G., Akin, J.: 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet (2015). https:\/\/doi.org\/10.1016\/S0140-6736(15)60308-7","journal-title":"Lancet"},{"key":"1314_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30073-3","author":"VH Thourani","year":"2016","unstructured":"Thourani, V.H., Kodali, S., Makkar, R.R., Herrmann, H.C., Williams, M., Babaliaros, V., Smalling, R., Lim, S., Malaisrie, S.C., Kapadia, S., Szeto, W.Y., Greason, K.L., Kereiakes, D., Ailawadi, G., Whisenant, B.K., Devireddy, C., Leipsic, J., Hahn, R.T., Pibarot, P., Weissman, N.J., Jaber, W.A., Cohen, D.J., Suri, R., Tuzcu, E.M., Svensson, L.G., Webb, J.G., Moses, J.W., MacK, M.J., Miller, D.C., Smith, C.R., Alu, M.C., Parvataneni, R., D\u2019Agostino, R.B., Leon, M.B.: Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet (2016). https:\/\/doi.org\/10.1016\/S0140-6736(16)30073-3","journal-title":"Lancet"},{"key":"1314_CR23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.022797","author":"HC Herrmann","year":"2016","unstructured":"Herrmann, H.C., Thourani, V.H., Kodali, S.K., Makkar, R.R., Szeto, W.Y., Anwaruddin, S., Desai, N., Lim, S., Malaisrie, S.C., Kereiakes, D.J., Ramee, S., Greason, K.L., Kapadia, S., Babaliaros, V., Hahn, R.T., Pibarot, P., Weissman, N.J., Leipsic, J., Whisenant, B.K., Webb, J.G., MacK, M.J., Leon, M.B.: One-year clinical outcomes with SAPIEN 3 transcatheter aortic valve replacement in high-risk and inoperable patients with severe aortic stenosis. Circulation (2016). https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.022797","journal-title":"Circulation"},{"key":"1314_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2018.1559600","author":"G Goodall","year":"2019","unstructured":"Goodall, G., Lamotte, M., Ramos, M., Maunoury, F., Pejchalova, B., de Pouvourville, G.: Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients. J. Med. Econ. (2019). https:\/\/doi.org\/10.1080\/13696998.2018.1559600","journal-title":"J. Med. Econ."},{"key":"1314_CR25","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","volume":"363","author":"MB Leon","year":"2010","unstructured":"Leon, M.B., Smith, C.R., Mack, M., Miller, D.C., Moses, J.W., Svensson, L.G., Tuzcu, E.M., Webb, J.G., Fontana, G.P., Makkar, R.R., Brown, D.L., Block, P.C., Guyton, R.A., Pichard, A.D., Bavaria, J.E., Herrmann, H.C., Douglas, P.S., Petersen, J.L., Akin, J.J., Anderson, W.N., Wang, D., Pocock, S.: Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363, 1597\u20131607 (2010). https:\/\/doi.org\/10.1056\/NEJMoa1008232","journal-title":"N. Engl. J. Med."},{"key":"1314_CR26","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2017.2039","author":"SJ Baron","year":"2017","unstructured":"Baron, S.J., Arnold, S.V., Wang, K., Magnuson, E.A., Chinnakondepali, K., Makkar, R., Herrmann, H.C., Kodali, S., Thourani, V.H., Kapadia, S., Svensson, L., Brown, D.L., Mack, M.J., Smith, C.R., Leon, M.B., Cohen, D.J.: Health status benefits of transcatheter vs surgical aortic valve replacement in patients with severe aortic stenosis at intermediate surgical risk: results from the PARTNER 2 randomized clinical trial. JAMA Cardiol. (2017). https:\/\/doi.org\/10.1001\/jamacardio.2017.2039","journal-title":"JAMA Cardiol."},{"key":"1314_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2018.02.032","author":"SJ Baron","year":"2018","unstructured":"Baron, S.J., Thourani, V.H., Kodali, S., Arnold, S.V., Wang, K., Magnuson, E.A., Pichard, A.D., Babaliaros, V., George, I., Miller, D.C., Tuzcu, E.M., Greason, K., Herrmann, H.C., Smith, C.R., Leon, M.B., Cohen, D.J.: Effect of SAPIEN 3 transcatheter valve implantation on health status in patients with severe aortic stenosis at intermediate surgical risk: results from the PARTNER S3i trial. JACC Cardiovasc. Interv. (2018). https:\/\/doi.org\/10.1016\/j.jcin.2018.02.032","journal-title":"JACC Cardiovasc. Interv."},{"key":"1314_CR28","unstructured":"Italian Ministry of Health: Remunerazione prestazioni di assistenza ospedaliera per acuti, assistenza ospedaliera di riabilitazione e di lungodegenza post acuzie e di assistenza specialistica ambulatoriale. In: Gazzetta Ufficiale - Serie Generale (2013)."},{"key":"1314_CR29","unstructured":"Italian Ministry of Health: Rapporto annuale sull\u2019 attivit\u00e0 di ricovero ospedaliero 2017, http:\/\/www.trovanorme.salute.gov.it\/norme\/renderPdf.spring?seriegu=SG&datagu=28\/01\/2013&redaz=13A00528&artp=3&art=1&subart=1&subart1=10&vers=1&prog=001."},{"key":"1314_CR30","unstructured":"Emilia-Romagna, G.R.: Determinazione delle tariffe per prestazioni di assistenza ospedaliera in strutture pubbliche e private accreditate dalla Regione Emilia-Romagna applicabili a decorrere dal 1.1.2004. (2004)."},{"key":"1314_CR31","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S36828","author":"P Piscitelli","year":"2012","unstructured":"Piscitelli, P., Iolascon, G., Argentiero, A., Chitano, G., Neglia, C., Marcucci, G., Pulimeno, M., Benvenuto, M., Mundi, S., Marzo, V., Donati, D., Baggiani, A., Migliore, A., Granata, M., Gimigliano, F., Di Blasio, R., Gimigliano, A., Renzulli, L., Brandi, M.L., Distante, A., Gimigliano, R.: Incidence and costs of hip fractures vs strokes and acute myocardial infarction in Italy: comparative analysis based on national hospitalization records. Clin. Interv. Aging. (2012). https:\/\/doi.org\/10.2147\/CIA.S36828","journal-title":"Clin. Interv. Aging."},{"key":"1314_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.04.1156","author":"G Callea","year":"2018","unstructured":"Callea, G., Borsoi, L., Tarricone, R.: Determinants and pathways of rehabilitation after surgical aortic valve replacement: a population-based, retrospective study with administrative data. Value Health. (2018). https:\/\/doi.org\/10.1016\/j.jval.2018.04.1156","journal-title":"Value Health."},{"key":"1314_CR33","doi-asserted-by":"publisher","unstructured":"Claxton, K., Martin, S., Soares, M., Rice, N., Spackman, E., Hinde, S., Devlin, N., Smith, P.C., Sculpher, M.: Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold. Health Technol. Assess. 19(14), 1\u2013503 (2015). https:\/\/doi.org\/10.3310\/hta19140","DOI":"10.3310\/hta19140"},{"key":"1314_CR34","doi-asserted-by":"crossref","unstructured":"Fattore, G.: Proposta di linee guida per la valutazione economica degli interventi sanitari in Italia. (2009).","DOI":"10.1007\/BF03320660"},{"key":"1314_CR35","doi-asserted-by":"crossref","unstructured":"Murdoch, D.J., Webb, J.G., Ye, J., Sathananthan, J., Hensey, M., Wood, D.A., Cheung, A., Leipsic, J., Blanke, P., Lauck, S.: Transcatheter aortic-valve replacement\u201410 years later. (2019).","DOI":"10.1056\/NEJMc1814932"},{"key":"1314_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2015.11.048","author":"H Takagi","year":"2016","unstructured":"Takagi, H., Umemoto, T.: Prosthesis\u2013patient mismatch after transcatheter aortic valve implantation. Ann. Thorac. Surg. (2016). https:\/\/doi.org\/10.1016\/j.athoracsur.2015.11.048","journal-title":"Ann. Thorac. Surg."},{"key":"1314_CR37","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.035236","author":"SJ Baron","year":"2019","unstructured":"Baron, S.J., Wang, K., House, J.A., Magnuson, E.A., Reynolds, M.R., Makkar, R., Herrmann, H.C., Kodali, S., Thourani, V.H., Kapadia, S., Svensson, L., Mack, M.J., Brown, D.L., Russo, M.J., Smith, C.R., Webb, J., Miller, C., Leon, M.B., Cohen, D.J.: Cost-effectiveness of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at intermediate risk. Circulation (2019). https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.035236","journal-title":"Circulation"},{"key":"1314_CR38","doi-asserted-by":"publisher","DOI":"10.2147\/CEOR.S208107","author":"JE Tarride","year":"2019","unstructured":"Tarride, J.E., Luong, T., Goodall, G., Burke, N., Blackhouse, G.: A Canadian cost-effectiveness analysis of SAPIEN 3 transcatheter aortic valve implantation compared with surgery, in intermediate and high-risk severe aortic stenosis patients. Clin. Outcomes Res. (2019). https:\/\/doi.org\/10.2147\/CEOR.S208107","journal-title":"Clin. Outcomes Res."},{"key":"1314_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2019.06.057","author":"J Zhou","year":"2019","unstructured":"Zhou, J., Liew, D., Duffy, S.J., Walton, A., Htun, N., Stub, D.: Cost-effectiveness of transcatheter aortic valve implantation compared to surgical aortic valve replacement in the intermediate surgical risk population. Int. J. Cardiol. (2019). https:\/\/doi.org\/10.1016\/j.ijcard.2019.06.057","journal-title":"Int. J. Cardiol."},{"key":"1314_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-016-0980-z","author":"S Filetti","year":"2017","unstructured":"Filetti, S., Ladenson, P.W., Biffoni, M., D\u2019Ambrosio, M.G., Giacomelli, L., Lopatriello, S.: The true cost of thyroid surgery determined by a micro-costing approach. Endocrine (2017). https:\/\/doi.org\/10.1007\/s12020-016-0980-z","journal-title":"Endocrine"},{"key":"1314_CR41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1814052","author":"MJ Mack","year":"2019","unstructured":"Mack, M.J., Leon, M.B., Thourani, V.H., Makkar, R., Kodali, S.K., Russo, M., Kapadia, S.R., Chris Malaisrie, S., Cohen, D.J., Pibarot, P., Leipsic, J., Hahn, R.T., Blanke, P., Williams, M.R., McCabe, J.M., Brown, D.L., Babaliaros, V., Goldman, S., Szeto, W.Y., Genereux, P., Pershad, A., Pocock, S.J., Alu, M.C., Webb, J.G., Smith, C.R.: Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N. Engl. J. Med. (2019). https:\/\/doi.org\/10.1056\/NEJMoa1814052","journal-title":"N. Engl. J. Med."},{"key":"1314_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-016-2631-5","author":"L Morelli","year":"2016","unstructured":"Morelli, L., Guadagni, S., Lorenzoni, V., Di Franco, G., Cobuccio, L., Palmeri, M., Caprili, G., D\u2019Isidoro, C., Moglia, A., Ferrari, V., Di Candio, G., Mosca, F., Turchetti, G.: Robot-assisted versus laparoscopic rectal resection for cancer in a single surgeon\u2019s experience: a cost analysis covering the initial 50 robotic cases with the da Vinci Si. Int. J. Colorectal Dis. (2016). https:\/\/doi.org\/10.1007\/s00384-016-2631-5","journal-title":"Int. J. Colorectal Dis."},{"key":"1314_CR43","doi-asserted-by":"crossref","unstructured":"Greenberg, D., Earle, C., Fang, C.H., Eldar-Lissai, A., Neumann, P.J.: When is cancer care cost-effective? A systematic overview of cost\u2013utility analyses in oncology. (2010).","DOI":"10.1093\/jnci\/djp472"},{"key":"1314_CR44","doi-asserted-by":"publisher","DOI":"10.5301\/grhta.5000182","author":"N Martone","year":"2014","unstructured":"Martone, N., Lucioni, C., Mazzi, S., Fadda, V.: Cost-effectiveness evaluation of oncological drugs newly marketed in Italy. Glob. Reg. Heal. Technol. Assess. Ital. North. Eur. Spanish. (2014). https:\/\/doi.org\/10.5301\/grhta.5000182","journal-title":"Glob. Reg. Heal. Technol. Assess. Ital. North. Eur. Spanish."},{"key":"1314_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2007.00298.x","author":"A Rocchi","year":"2008","unstructured":"Rocchi, A., Menon, D., Verma, S., Miller, E.: The role of economic evidence in Canadian oncology reimbursement decision-making: To lambda and beyond. Value Health. (2008). https:\/\/doi.org\/10.1111\/j.1524-4733.2007.00298.x","journal-title":"Value Health."},{"key":"1314_CR46","doi-asserted-by":"crossref","unstructured":"Raftery, J.: NICE and the challenge of cancer drugs. (2009).","DOI":"10.1136\/bmj.b67"},{"key":"1314_CR47","doi-asserted-by":"crossref","unstructured":"Thivilliers, A.P., Ladarr\u00e9, R., Merabti, O., Fran\u00e7ois, C., Fontenay, S., Van Den Brink, H., Pineau, J., Prognon, P., Borget, I., Martelli, N.: The learning curve in transcatheter aortic valve implantation clinical studies: a systematic review. (2020).","DOI":"10.1017\/S0266462320000100"},{"key":"1314_CR48","doi-asserted-by":"publisher","first-page":"394","DOI":"10.12688\/f1000research.18796.5","volume":"8","author":"K Marsh","year":"2021","unstructured":"Marsh, K., Hawken, N., Brookes, E., Kuehn, C., Liden, B.: Patient-centered benefit\u2013risk analysis of transcatheter aortic valve replacement. F1000Research. 8, 394 (2021). https:\/\/doi.org\/10.12688\/f1000research.18796.5","journal-title":"F1000Research."}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-021-01314-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10198-021-01314-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-021-01314-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T16:06:56Z","timestamp":1635696416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10198-021-01314-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1314"],"URL":"https:\/\/doi.org\/10.1007\/s10198-021-01314-z","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,21]]},"assertion":[{"value":"29 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"VL, FS, FM, GLM and GT declared they have no conflict of interest to declare. SB declared the following conflict of interests: Proctor Edwards, Proctor Abbott, Proctor Boston Scientific. AGC declared the following conflict of interests: Consultant for Boston Scientific, Consultant for GADA Italia, Consultant for Livanova, AGC has also received speaker fees from Edwards Lifesciences within the past three years. GB and PC are full employees of Edwards Lifesciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}